GLIOBLASTOMA "SUICIDE-GENE THERAPY" MORE EFFECTIVE THAN
EXPECTED, BUT LESS SAFE Glioblastoma 'suicide-gene therapy,' already in
clinical trials in humans, causes a chronic inflammatory response,
demyelination and axonal degeneration in the brains of rats 3 months after
treatment. http://oncology.medscape.com/13617.rhtml <a
href="http://oncology.medscape.com/13617.rhtml">Read it
Here</a>